PreAxia Health Care Payment Systems Inc. Files Form 8-K: Announces Material Errors in Financial Statements and Plans Restatement

Key Highlights:

• PreAxia Health Care Payment Systems Inc. (“PreAxia” or “the Company”) has identified material errors in its previously released financial statements for the three months ended August 31, 2025.
• The Company has announced that these financial statements should no longer be relied upon and will be restated.
• The errors relate to stock award valuation and timing, and a lack of option disclosures.
• The Company has acknowledged a continuing material weakness in its internal controls over financial reporting and disclosure controls.
• Both the former and current independent auditors have been informed, and the current auditor (M&K CPAs) will oversee the review of the amended financial statements.

Detailed Report

PreAxia Health Care Payment Systems Inc., a Nevada corporation, has filed a Form 8-K with the Securities and Exchange Commission (SEC) to inform investors and stakeholders of significant developments regarding its financial reporting. On April 9, 2026, PreAxia’s management identified material errors in the previously released financial statements for the quarter ended August 31, 2025 (the “Non-Reliance Period”).

The Company’s management determined that these errors are substantial enough that the aforementioned financial statements should no longer be relied upon by investors, analysts, or the market. Specifically, the errors are related to:

• Stock award valuation and timing issues: The Company disclosed that the valuation and timing of stock awards during the Non-Reliance Period were misstated.
• Lack of option disclosures: The financial statements failed to adequately disclose information related to stock options.

As a result, PreAxia will file amended Quarterly Reports on Form 10-Q for the three months ended August 31, 2025, which will include corrected financial statements reflecting the necessary adjustments. This restatement is considered material and affects all previously issued or filed reports, press releases, earnings releases, and investor presentations or other communications regarding the Company’s financial statements for the Non-Reliance Period. Shareholders and market participants are strongly advised not to rely on any of these previous communications.

Internal Controls and Material Weaknesses:

Management has assessed the impact of these errors and concluded that there is a continuing material weakness in the Company’s internal control over financial reporting and its disclosure controls and procedures. A material weakness is defined as a deficiency in internal control such that there is a reasonable possibility that a material misstatement of the financial statements will not be prevented or detected on a timely basis. As a result, management believes that its internal controls and disclosure controls were not effective during the Non-Reliance Periods.

Auditor Involvement:

The Company’s management has discussed these matters with both its former auditor, Fruci & Associates, CPAs, and its current independent registered public accounting firm, M&K CPAs. The current auditor, M&K CPAs, will oversee the review of the amended financial statements to be included in the restated filings.

Potential Price Sensitivity and Impact for Shareholders:

• The announcement of material errors, the need for restatement, and the acknowledgment of ongoing internal control weaknesses are highly price-sensitive disclosures. Such issues can undermine investor confidence, impact the Company’s stock price, and may affect the Company’s ability to raise capital or meet listing requirements.
• Shareholders should closely monitor future filings from PreAxia, as the restated financials may differ significantly from previous reports. These changes may also impact the assessment of the Company’s financial health, historical performance, and future prospects.

Conclusion

This Form 8-K filing signals a critical development for PreAxia Health Care Payment Systems Inc. The Company’s admission of material errors, the necessity for financial restatements, and the acknowledgment of ongoing internal control deficiencies are significant red flags for investors. These developments could affect the Company’s market value, trigger volatility, and prompt regulatory or compliance scrutiny. Investors are advised to exercise caution and await the amended financial statements before making any investment decisions regarding PreAxia.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their financial advisors and review all relevant filings and disclosures before making any investment decisions. The author and publisher assume no responsibility or liability for any actions taken based on the information provided in this article.

View PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. Historical chart here